← Back to Search

Parent Supported Weight Reduction in Down Syndrome

N/A
Waitlist Available
Led By Richard K Fleming, PhD
Research Sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to determine whether a nutrition and physical activity education program for families of overweight or obese adolescents with Down syndrome is more effective when behavioral lifestyle change strategies are added.

Eligible Conditions
  • Down Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: NAE + Behavioral InterventionExperimental Treatment2 Interventions
Parents of participants receive training in behavioral support at home, in addition to a standard nutrition and physical activity education (NAE) program.
Group II: Nutrition/Activity EducationActive Control1 Intervention
Parents and participants receive a standard nutrition and physical activity education (NAE) program.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Parent Supported Behavioral Intervention
2006
N/A
~30
Nutrition/Activity Education (NAE)
2006
N/A
~30

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Lead Sponsor
2,464 Previous Clinical Trials
4,337,432 Total Patients Enrolled
University of Massachusetts, WorcesterOTHER
362 Previous Clinical Trials
992,699 Total Patients Enrolled
Richard K Fleming, PhDPrincipal InvestigatorUniversity of Massachusetts Medical School, Eunice Kennedy Shriver Center
1 Previous Clinical Trials
31 Total Patients Enrolled
~1 spots leftby Jan 2026